Compare AIR & PBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AIR | PBH |
|---|---|---|
| Founded | 1951 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Aerospace | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 2.9B |
| IPO Year | 1988 | 2005 |
| Metric | AIR | PBH |
|---|---|---|
| Price | $84.72 | $61.21 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 5 |
| Target Price | ★ $91.20 | $86.40 |
| AVG Volume (30 Days) | 332.7K | ★ 413.0K |
| Earning Date | 01-06-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.81 | ★ 4.04 |
| Revenue | ★ $2,858,400,000.00 | $1,110,479,000.00 |
| Revenue This Year | $14.44 | N/A |
| Revenue Next Year | $10.40 | $2.50 |
| P/E Ratio | $104.39 | ★ $15.15 |
| Revenue Growth | ★ 17.59 | N/A |
| 52 Week Low | $46.51 | $57.25 |
| 52 Week High | $89.69 | $90.04 |
| Indicator | AIR | PBH |
|---|---|---|
| Relative Strength Index (RSI) | 54.75 | 48.45 |
| Support Level | $78.62 | $61.72 |
| Resistance Level | $87.46 | $63.91 |
| Average True Range (ATR) | 2.27 | 1.26 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 57.44 | 30.61 |
AAR Corp is engaged in providing products and services to aviation, government and defense market. It operates in segments namely: The parts supply segment majorly consists of sales and leasing of USM and aftermarket distribution of new, OEM-supplied replacement parts; Repair & Engineering segment provides airframe maintenance, component repair, and landing gear overhaul services; Integrated Solutions segment consists of its fleet management and operations of customer-owned aircraft, customized performance-based supply chain logistics programs in support of the U.S. Department of Defense, flight hour component inventory; and The Expeditionary Services segment consists of products and services supporting the movement of equipment and personnel by the U.S. and foreign governments and NGOs.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.